Diagnosis and treatment of primary aldosteronism: practical clinical perspectives.
William F YoungPublished in: Journal of internal medicine (2018)
Primary aldosteronism (PA), the most common form of secondary hypertension, can be either surgically cured or treated with targeted pharmacotherapy. PA is frequently undiagnosed and untreated, leading to aldosterone-specific cardiovascular morbidity and nephrotoxicity. Thus, clinicians should perform case detection testing for PA at least once in all patients with hypertension. Confirmatory testing is indicated in most patients with positive case detection testing results. The next step is to determine whether patients with confirmed PA have a disease that can be cured with surgery or whether it should be treated medically; this step is guided by computed tomography scan of the adrenal glands and adrenal venous sampling. With appropriate surgical expertise, laparoscopic unilateral adrenalectomy is safe, efficient and curative in patients with unilateral adrenal disease. In patients who have bilateral aldosterone hypersecretion, the optimal management is a low-sodium diet and lifelong treatment with a mineralocorticoid receptor antagonist administered at a dosage to maintain a high-normal serum potassium concentration without the aid of oral potassium supplements.
Keyphrases
- computed tomography
- blood pressure
- newly diagnosed
- end stage renal disease
- prognostic factors
- chronic kidney disease
- ejection fraction
- loop mediated isothermal amplification
- minimally invasive
- angiotensin ii
- positron emission tomography
- label free
- physical activity
- palliative care
- magnetic resonance imaging
- real time pcr
- weight loss
- peritoneal dialysis
- cancer therapy
- dual energy
- smoking cessation
- coronary artery disease
- drug induced
- case report
- patient reported outcomes
- pet ct